A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery
Phase 1/2 Recruiting
55 enrolled
Amelia-1
Phase 1/2 Recruiting
52 enrolled
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Phase 1 Recruiting
241 enrolled
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Phase 1 Recruiting
258 enrolled
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
Phase 1 Recruiting
42 enrolled
HER2 Vaccine for Locally Advanced Breast Cancer
Phase 1 Recruiting
36 enrolled
PREDICT-RD
Phase 2 Recruiting
78 enrolled
I-MAMMO
Phase 2 Recruiting
364 enrolled
ALLIANCE
Phase NA Recruiting
174 enrolled
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
Phase 1 Recruiting
86 enrolled
MAMO
Phase NA Recruiting
1,020 enrolled
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery
Phase NA Recruiting
80 enrolled
ELAINEIII
Phase 3 Recruiting
500 enrolled
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Phase 3 Recruiting
3,680 enrolled
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
Phase 1 Recruiting
20 enrolled
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Phase 1 Recruiting
150 enrolled
LINFO
Phase NA Recruiting
155 enrolled
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Phase 1/2 Recruiting
100 enrolled
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Phase 1 Recruiting
150 enrolled
MoonROSE
Phase 1/2 Recruiting
285 enrolled
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Phase 3 Recruiting
558 enrolled
A Study of the TheraBionic P1 Device in Breast Cancer
Phase NA Recruiting
24 enrolled
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Phase 1 Recruiting
180 enrolled
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Phase 1 Recruiting
138 enrolled
FACT-TN
Phase 2 Recruiting
80 enrolled
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Phase 1 Recruiting
63 enrolled
Effectiveness of a Visual Biofeedback Program Versus Conventional Physiotherapy on Shoulder Mobility, Strength, and Function in Women After Breast Cancer Surgery
Phase NA Recruiting
40 enrolled
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Phase 2 Recruiting
285 enrolled
EUTACAM
Phase NA Recruiting
200 enrolled
CAPItello-292
Phase 3 Recruiting
895 enrolled
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 Recruiting
714 enrolled
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
Phase 2 Recruiting
35 enrolled
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
Phase 1/2 Recruiting
204 enrolled
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Phase 1 Recruiting
85 enrolled
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
124 enrolled
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
Phase 1/2 Recruiting
152 enrolled
NEXUS-01
Phase 1 Recruiting
420 enrolled
TroFuse-011
Phase 3 Recruiting
1,000 enrolled
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
260 enrolled
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
Phase 2 Recruiting
80 enrolled
An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy
Phase NA Recruiting
40 enrolled
2025-370
Phase 2 Recruiting
92 enrolled
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
Phase 2 Recruiting
70 enrolled
ADARNAT
Phase NA Recruiting
820 enrolled
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Phase 2 Recruiting
55 enrolled
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial
Phase 2 Recruiting
174 enrolled
ANGEL
Phase NA Recruiting
2,706 enrolled
ECLECTIC
Phase 3 Recruiting
300 enrolled
Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity
Phase 2 Recruiting
46 enrolled
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
Phase 2 Recruiting
29 enrolled